Evoke Pharma
Priced, Nasdaq: EVOKDeveloping drugs to treat gastrointestinal disorders and diseases.
Industry: Health Care
First Day Return: -2.2%
EVOK
Developing drugs to treat gastrointestinal disorders and diseases.
| IPO Date | 09/24/2013 |
|---|---|
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $25 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| IPO Intelligence Only |
| Headquarters | San Diego, CA, United States |
|---|---|
| Founded | 2007 |
| Employees at IPO | 2 |
| Website www.evokepharma.com | |
IPO News for Evoke Pharma
Evoke Pharma (EVOK) Performance
